Visualizing Lower-Burden Treatment Options for DME and nAMD

Program Overview

Watch as renowned retina specialists David A. Eichenbaum, MD and Ferhina S. Ali, MD, MPH, FASRS delve into innovative strategies designed to reduce the treatment burden for patients with diabetic macular edema (DME) and neovascular age-related macular degeneration (nAMD). Adding a personal touch, a patient will share her compelling treatment journey and the profound impact of nAMD on her life. The panel will also provide practical tips on integrating these new strategies into clinical practice, ensuring you leave with actionable insights to enhance patient care.

Credit Expired

Target Audience

Retina specialists and ophthalmology clinicians

Educational Objectives

Upon completion of this activity, participants should be better able to:

  • Implement strategies to alleviate patient and caregiver burden associated with the treatment of DME and nAMD
  • Utilize evidence from clinical trials and real-world studies to select low-burden treatment options for patients with DME or nAMD

Activity Faculty

19-25-1684-VL001 DME & nAMD Faculty headshot EichenbaumCMYK

David A. Eichenbaum, MD

President
Retina Consultants of Tampa Bay
St. Petersburg, FL

19-25-1684-VL001 DME & nAMD Faculty headshot Dr Ali RGB

Ferhina S. Ali, MD, MPH, FASRS

Assistant Professor, Ophthalmology
Valhalla, NY
Physician and Surgeon, Vitreoretinal
Westchester Medical Center/Advanced Physician Services
Hawthorne, NY

19-25-1684-VL Patient

Nancy, Patient Panelist

Subscribe

Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources